LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 3 of total 3

Search options

  1. Article: Persistent or new symptoms 1 year after a single high dose of vitamin D

    Fernandes, Alan L / Sales, Lucas P / Santos, Mayara D / Caparbo, Valeria F / Murai, Igor H / Pereira, Rosa M R

    Frontiers in nutrition

    2022  Volume 9, Page(s) 979667

    Abstract: Purpose: The aim of this study was to investigate the reported persistent or new symptoms 1 year after a single dose of 200,000 IU of vitamin D: Methods: This is a : Results: Between 2 June and 27 August 2020, we randomized 240 patients of which ... ...

    Abstract Purpose: The aim of this study was to investigate the reported persistent or new symptoms 1 year after a single dose of 200,000 IU of vitamin D
    Methods: This is a
    Results: Between 2 June and 27 August 2020, we randomized 240 patients of which 144 were included in this study [the vitamin D
    Conclusion: The findings do not support the use of 200,000 IU of vitamin D
    Language English
    Publishing date 2022-09-13
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2776676-7
    ISSN 2296-861X
    ISSN 2296-861X
    DOI 10.3389/fnut.2022.979667
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Effect of a single high dose of vitamin D3 on cytokines, chemokines, and growth factor in patients with moderate to severe COVID-19.

    Fernandes, Alan L / Murai, Igor H / Reis, Bruna Z / Sales, Lucas P / Santos, Mayara D / Pinto, Ana J / Goessler, Karla F / Duran, Camila S C / Silva, Carla B R / Franco, André S / Macedo, Marina B / Dalmolin, Henrique H H / Baggio, Janaina / Balbi, Guilherme G M / Antonangelo, Leila / Caparbo, Valeria F / Gualano, Bruno / Pereira, Rosa M R

    The American journal of clinical nutrition

    2022  Volume 115, Issue 3, Page(s) 790–798

    Abstract: Background: The modulating effect of vitamin D on cytokine concentrations in severe coronavirus disease 2019 (COVID-19) remains unknown.: Objectives: We aimed to investigate the effect of a single high dose of vitamin D3 on cytokines, chemokines, and ...

    Abstract Background: The modulating effect of vitamin D on cytokine concentrations in severe coronavirus disease 2019 (COVID-19) remains unknown.
    Objectives: We aimed to investigate the effect of a single high dose of vitamin D3 on cytokines, chemokines, and growth factor in hospitalized patients with moderate to severe COVID-19.
    Methods: This is a post hoc, ancillary, and exploratory analysis from a multicenter, double-blind, placebo-controlled, randomized clinical trial. Patients with moderate to severe COVID-19 were recruited from 2 hospitals in São Paulo, Brazil. Of 240 randomly assigned patients, 200 were assessed in this study and randomly assigned to receive a single oral dose of 200,000 IU vitamin D3 (n = 101) or placebo (n = 99). The primary outcome was hospital length of stay, which has been published in our previous study. The prespecified secondary outcomes were serum concentrations of IL-1β, IL-6, IL-10, TNF-α, and 25-hydroxyvitamin D. The post hoc exploratory secondary outcomes were IL-4, IL-12p70, IL-17A, IFN-γ, granulocyte-macrophage colony-stimulating factor (GM-CSF), IL-8, IFN-inducible protein-10 (IP-10), macrophage inflammatory protein-1β (MIP-1β), monocyte chemoattractant protein-1 (MCP-1), vascular endothelial growth factor (VEGF), and leukocyte count. Generalized estimating equations for repeated measures, with Bonferroni's adjustment, were used for testing all outcomes.
    Results: The study included 200 patients with a mean ± SD age of 55.5 ± 14.3 y and BMI of 32.2 ± 7.1 kg/m2, of which 109 (54.5%) were male. GM-CSF concentrations showed a significant group-by-time interaction effect (P = 0.04), although the between-group difference at postintervention after Bonferroni's adjustment was not significant. No significant effects were observed for the other outcomes.
    Conclusions: The findings do not support the use of a single dose of 200,000 IU vitamin D3, compared with placebo, for the improvement of cytokines, chemokines, and growth factor in hospitalized patients with moderate to severe COVID-19.This trial was registered at clinicaltrials.gov as NCT04449718.
    MeSH term(s) Adult ; Aged ; Brazil ; COVID-19/immunology ; Chemokines/drug effects ; Cholecalciferol/administration & dosage ; Cytokines/drug effects ; Double-Blind Method ; Female ; Granulocyte-Macrophage Colony-Stimulating Factor/drug effects ; Humans ; Intercellular Signaling Peptides and Proteins/blood ; Male ; Middle Aged ; SARS-CoV-2/immunology ; Vascular Endothelial Growth Factor A/drug effects ; Vitamins/administration & dosage ; COVID-19 Drug Treatment
    Chemical Substances Chemokines ; Cytokines ; Intercellular Signaling Peptides and Proteins ; Vascular Endothelial Growth Factor A ; Vitamins ; Cholecalciferol (1C6V77QF41) ; Granulocyte-Macrophage Colony-Stimulating Factor (83869-56-1)
    Language English
    Publishing date 2022-01-12
    Publishing country United States
    Document type Journal Article ; Multicenter Study ; Randomized Controlled Trial ; Research Support, Non-U.S. Gov't
    ZDB-ID 280048-2
    ISSN 1938-3207 ; 0002-9165
    ISSN (online) 1938-3207
    ISSN 0002-9165
    DOI 10.1093/ajcn/nqab426
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Influence of vitamin D status on hospital length of stay and prognosis in hospitalized patients with moderate to severe COVID-19: a multicenter prospective cohort study.

    Reis, Bruna Z / Fernandes, Alan L / Sales, Lucas P / Santos, Mayara D / Dos Santos, Caroline C / Pinto, Ana J / Goessler, Karla F / Franco, Andre S / Duran, Camila S C / Silva, Carla B R / Macêdo, Marina B / Dalmolin, Henrique H H / Baggio, Janaína / Balbi, Guilherme G M / Antonangelo, Leila / Caparbo, Valeria F / Gualano, Bruno / Murai, Igor H / Pereira, Rosa M R

    The American journal of clinical nutrition

    2021  Volume 114, Issue 2, Page(s) 598–604

    Abstract: Background: Vitamin D acts as a mediator in the immune system regulating antiviral mechanisms and inflammatory processes. Vitamin D insufficiency has been suggested as a potential risk factor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV- ...

    Abstract Background: Vitamin D acts as a mediator in the immune system regulating antiviral mechanisms and inflammatory processes. Vitamin D insufficiency has been suggested as a potential risk factor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, although its impact on the prognosis of hospitalized patients with coronavirus disease 2019 (COVID-19) remains unclear.
    Objective: This multicenter prospective cohort study was designed to investigate whether serum 25-hydroxyvitamin D [25(OH)D] concentration is associated with hospital length of stay and prognosis in hospitalized patients with COVID-19.
    Methods: Patients with moderate to severe COVID-19 (n = 220) were recruited from 2 hospitals in Sao Paulo, Brazil. Serum 25(OH)D concentrations were categorized as follows: <10 ng/mL, 10 to <20 ng/mL, 20 to <30 ng/mL, and ≥30 ng/mL, and <10 ng/mL and ≥10 ng/mL. The primary outcome was hospital length of stay and the secondary outcomes were the rate of patients who required invasive mechanical ventilation and mortality.
    Results: There were no significant differences in hospital length of stay when the 4 25(OH)D categories were compared (P = 0.120). Patients exhibiting 25(OH)D <10 ng/mL showed a trend (P = 0.057) for longer hospital length of stay compared with those with 25(OH)D ≥10 ng/mL [9.0 d (95% CI: 6.4, 11.6 d) vs. 7.0 d (95% CI: 6.6, 7.4 d)]. The multivariable Cox proportional hazard models showed no significant associations between 25(OH)D and primary or secondary outcomes.
    Conclusions: Among hospitalized patients with moderate to severe COVID-19, those with severe 25(OH)D deficiency (<10 ng/mL) exhibited a trend for longer hospital length of stay compared with patients with higher 25(OH)D concentrations. This association was not significant in the multivariable Cox regression model. Prospective studies should test whether correcting severe 25(OH)D deficiency could improve the prognosis of patients with COVID-19.
    MeSH term(s) Adult ; Aged ; Brazil/epidemiology ; COVID-19/blood ; COVID-19/diagnosis ; COVID-19/mortality ; Female ; Hospital Mortality ; Hospitals ; Humans ; Length of Stay ; Male ; Middle Aged ; Prognosis ; Proportional Hazards Models ; Prospective Studies ; Respiration, Artificial ; SARS-CoV-2 ; Severity of Illness Index ; Vitamin D/analogs & derivatives ; Vitamin D/blood ; Vitamin D Deficiency/blood ; Vitamin D Deficiency/complications ; Vitamins
    Chemical Substances Vitamins ; Vitamin D (1406-16-2) ; 25-hydroxyvitamin D (A288AR3C9H)
    Language English
    Publishing date 2021-05-24
    Publishing country United States
    Document type Journal Article ; Multicenter Study ; Research Support, Non-U.S. Gov't
    ZDB-ID 280048-2
    ISSN 1938-3207 ; 0002-9165
    ISSN (online) 1938-3207
    ISSN 0002-9165
    DOI 10.1093/ajcn/nqab151
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top